Other Services

This Service

A database built with INDRA combining content from numerous readers and databases. This page allows you to curate the loaded statements. For more information please see the manual.

This Project

INDRA is developed by indralabs, a part of the Harvard Medical School Laboratory of Systems Pharmacology.

This project, indra_db, is also developed by the indralab team. For more information on how we procure our sources, you can go here. This work was funded by ARO grant W911NF‐15‐1‐0544 under the DARPA Communicating with Computers program.

IndraLab

Statements

CEP131 activates USP9X. 1 / 1

| 1

➶

reach

"These results suggest that CEP131 functions cooperatively with but independently of other USP9X substrates in USP9X promoted breast cancer cell survival, and also provide an explanation for why overexpression of CEP131 could not fully restore the growth of USP9X knocked down tumour cells."

28361952

Our Sources:

INDRA allows us to combine the results from a multitude of sources. In particular, the INDRA Database draws on the following...